Phase IV Study to Investigate if Valproate Add-on Therapy is Superior to Quetiapine Monotherapy in Acutely Manic Patients.
Phase of Trial: Phase IV
Latest Information Update: 02 Feb 2013
At a glance
- Drugs Valproic acid (Primary) ; Quetiapine
- Indications Bipolar disorders
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 31 Aug 2018 Biomarkers information updated
- 02 Feb 2013 NCT reports actual initiation date as Jul 2005 and actual patient number as 17.
- 25 Jan 2013 Actual end date Jun 2006 added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History